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Household Air Pollution and CVD
Identifying Best Directions for Research
Michael Lauer *, H. Eser Tolunay *, Jill Baumgartner ,, Gerald S. Bloomﬁeld §, Lawrence Fine *,
Arun Chockalingam k
Bethesda, MD, USA; St. Paul, MN, USA; Durham, NC, USA; and Beijing, ChinaWe face an increasing global burden of cardiovas-
cular disease, principally due to a sharp rise in devel-
oping countries experiencing health transitions.
Though it has long been known that hypertension,
cigarette smoking, hypercholesterolemia, and dia-
betes are important cardiovascular risk factors, it is
now increasingly appreciated that environmental
factors such as ﬁne-particulate air pollution represent
a serious public health threat. As noted by Rajagopo-
lan and Brook [1] in this issue, household air pollu-
tion from use of coal and biomass for cooking
and space heating may well have a substantial, and
potentially reversible, cardiovascular impact. Rajago-
polan and Brook call for a concerted research
program to estimate the impact and to develop and
test interventions. They correctly note that there is
a need to balance the cost of research with the neces-
sity of additional information. Further, they identify
5 focus areas, including exposure assessment, biolog-
ical mechanisms, epidemiology, candidate interven-
tions, and cost-effectiveness. They argue that
multidisciplinary teams are best equipped to tackle
this complex issue from both scientiﬁc and societal
perspectives.
Research, like many other goods and services, is
a scarce resource for which we have to make difﬁcult
decisions about expected returns and opportunity
costs. There is no question that properly done research
offers substantive beneﬁts at reasonable rates of return.
Cutler and Kadiyala [2] analyzed the impact of
research on cardiovascular health in theUnited States.
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M. Lauer (Michael.Lauer@nih.gov).mortality seen over the last 50 years could be attributed
to 3 major factors: high-technology care, low-
technology care, and behavioral change. Quite
remarkably, these declines have continued as age-
adjusted death rates for coronary heart disease in the
United States have declined from 187 deaths per
100,000 population in 2000 to 123 deaths per
100,000 in 2008 [3]. High-technology care includes
coronary care units, cardiac surgery, and devices such
as implantable deﬁbrillators and circulatory support
pumps. Low-technology care includes medical
therapy for hypertension and hypercholesterolemia,
as well as aspirin prophylaxis in appropriate patients.
Behavioral changes include declines in cigarette
smoking and changes in dietary fat intake. For identi-
fying all 3 of these areasdhigh-technology care, low-
technology care, and behavioral changedwe can
conﬁdently say that biomedical research played a crit-
ical role.Were it not for biomedical research, coronary
heart disease mortality rates might well be nearly 4
higher (405,000 of 1,579,000) in the United States
[4]. Cutler and Kadiyala [2] estimated that the
societal rate of return on biomedical research and
cardiovascular disease is at least 4 to 1. Cardiovascular
research, at least in high-income countries, has been
an outstanding investment [5]. Given the large
burden of cardiovascular disease in low- and middle-
income countries, the persistent use of solid fuels
globally, and the hypothesized cardiovascular effects
of solid fuel smoke, we see a window of opportunity
for research that could lead to positive impacts on
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How can we ensure reasonable returns on the
investment in biomedical research on the association
between household air pollution and cardiovascular
disease? What criteria should we use to rank prior-
ities? How do we best leverage existing resources?
How do we incorporate existing knowledge about
the effects of ambient air pollution on blood pres-
sure, myocardial ischemia, endothelial function,
and inﬂammation? What proportion of resources
should we dedicate toward fundamental and mech-
anistic, as opposed to applied research? Is it really
necessary to elucidate mechanisms of disease when
prior public health threats, such as smallpox and
cholera, were largely conquered in the absence of
such information? What proportion of resources
should we dedicate toward implementation research
versus the testing of new interventions? Should
research funders primarily support large multidisci-
plinary groups, or focus on individual investigators
working in relatively small laboratories or clinical
research units? What proportion of a portfolio
should go to funding “big science” projects? These
are all difﬁcult questions; questions that highlight
substantial opportunity costs regardless of how
reasoned our decisions are.
Research on the cardiovascular effects of house-
hold air pollution is by necessity of interest to
multiple stakeholders, including researchers, policy-
makers, and implementers across the health, energy,
and development sectors. There is increasing interest
in developing systematic approaches to involve
diverse stakeholder groups in the development and
implementation of research priorities. For example,
one group recently developed and piloted “a stake-
holder informed approach” to prioritize comparative
effectiveness research on genomic tests for cancer
[6]. After performing a “landscape analysis” to iden-
tify candidate topics for research, the investigators
sought to identify domains of high interest to diverse
thought leaders and stakeholders, including patient
advocacy groups, payers, manufacturers, leaders,
policymakers, and community physicians. The
investigators identiﬁed 9 critical domains, namely
population impact, current standards of care, esti-
mated strength of association, potential clinical
beneﬁts, potential harms, economic impacts,
evidence of need, trial feasibility, and market factors.
We might anticipate that these domains and others,
like equity concerns, would be of variable interest to
stakeholders in the cardiovascular impact of house-
hold air pollution. We might want to considerbuilding on work like this to identify and engage
key stakeholders and thereby prospectively identify
our best criteria for research prioritization.
Within the sphere of clinical and population
science, we need to make decisions about the rela-
tive importance of observational epidemiology,
randomized trials, and novel program evaluation
techniques that take advantage of natural experi-
ments (Table 1). Observational epidemiology
cohort studies can provide invaluable insights into
candidate dose-response associations and possible
confounders or mediators, whereas nested case-
control studies built on existing cohorts can identify
candidate biological pathways. Nonetheless, it is
difﬁcult to draw deﬁnitive conclusions from obser-
vational studies, given the potential impact of
confounders such as climate, altitude, humidity,
socioeconomic status, culture, diet, physical activity,
and pollution from other sources. Randomized trials
offer a high level of evidence unencumbered by
unmeasured confounding, but also present sub-
stantial expense and logistical challenges (though
prospective cohort studies also present complex
logistical challenges). Today, only one completed
randomized trial has assessed the health impacts
of a chimney-stove intervention [7,8]. Natural
experiments such as large-scale distribution of
advanced biomass cook stoves with improved efﬁ-
ciency can take advantage of ongoing intervention
programs and inform research by incorporating
sophisticated analytical techniques in program eval-
uation. If properly done, analyses of natural experi-
ments offer a cost-effective method for evaluating
the potential public health impact of interventions.
Nonetheless, a recent study illustrates the potential
for signiﬁcant bias in nonrandomized intervention
studies due to limited controls for confounding
inﬂuences of nonstove factors, particularly when
assessing health beneﬁts [9]. Another challenge is
that technologies that reduce household air pollu-
tion will continue to evolve over time so that by
the time an intervention has been tested it may
have been replaced by a new innovation.
T E AM SC I E N C E
It may seem intuitively obvious that research teams
reﬂecting diverse, multidisciplinary backgrounds
are more likely to be productive than individual
investigators or small research groups are. Theoret-
ical and empirical evidence supports the application
of diverse, multidisciplinary approaches to problem
solving. However, the beneﬁts are often more
Table 1. Potential research examples
Research question Proposed research and design
Association between HAP and CVD Surveillance studies such as interrupted time series to measure the effect of
large-scale interventions to reduce HAP on hard CV endpoints and surrogate
measures (e.g., blood pressure) in multicountry, multiethnic, and at-risk groups.
May be incorporated into existing cohorts.
Relationship between personal exposure level
and CV risk and outcomes
Cohort studies taking into account other risk factors (e.g., tobacco smoking,
climate, altitude).
May be incorporated into existing cohorts.
Impact of HAP exposure on CV clinical outcomes
including CVD death
Case-control studies.
Acute effects of recent exposures (e.g., hours to days) and/or retrospective
analysis of chronic effects using long-term exposure histories.
Smaller samples possible.
Association between HAP and CV morbidity
and mortality
Prospective long-term cohort studies including personal exposure levels and time
course of exposure and CVD relationship.
Impact of new cook stoves or air ﬁltration
on CVD
RCT with sensitive CV risk surrogate markers (e.g., blood pressure) and, if feasible,
hard CV outcomes.
Best performed in multiple countries to capture regional differences in risk
propensity and HAP exposure.
CV, cardiovascular; CVD, cardiovascular disease; HAP, household air pollution; RCT, randomized controlled trials.
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273modest than one might think, and even when
present require certain pre-conditions. Diversity of
approach works best when dealing with complex
problems, when there is an ample supply of skilled
problem solvers, and when there is sufﬁcient diver-
sity such that different groups of people will be able
to leverage other groups’ solutions [10]. As noted by
Rajagopolan and Brook [1], these pre-conditions
almost certainly exist in the case of cardiovascular
disease and household air pollution. A particularly
important challenge will be to promote involvement
of in-country research collaborators, nongovern-
mental organizations, and policymakers.ACCOUNTAB I L I T Y FOR D I R E C T I ONS
CHO S EN
Once concerted research programs are underway,
how and when do we evaluate their progress?
“Results-based accountability” represents an
approach by which governments and nonproﬁt fun-
ders evaluate the success or failure of their programs
[11]. This approach has already been well tested for
public health programs, such as a successful inter-
vention to reduce teen pregnancy rates in Tillamook
County, Oregon [12]. Brieﬂy, we will need to
prospectively identify “headline metrics” that arealigned with the goals and anticipated impact of
any research programs we choose to fund. For basic
science projects, we might choose to focus on
publications in high-impact journals, citations, and
innovative collaborations that lead to novel experi-
ments. For applied projects, we might choose to
focus on development of appropriate technological
interventions that are ripe for clinical or community
testing, as well as actual changes in intervention
delivery, or public policy that lead to reduced pollu-
tion emissions and improved population cardiovas-
cular health.
Once we have identiﬁed headline metrics, we
track them and make forecasts about how they
would be expected to behave were we to “continue
business as usual.” We then tell stories behind the
trends and forecasts and use those stories to identify
potentially valuable partnerships in changes in
direction. A key point is that we do not use metrics
to tell us what to do; instead, we use metrics as tools
to help us identify best strategies.CONC LU S I ON S
Persistent household use of biomass and coal and
growing cardiovascular disease burdens are major,
and potentially connected, challenges facing
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274governments, public health workers, research fun-
ders, and researchers. If we have learned anything
from our experience in dealing with the American
cardiovascular epidemic of the 20th century, it is
that health research is absolutely essential to identify
optimal solutions. Opportunities such as advanced
biomass cook stoves developed over the past decade;
low-cost, portable devices that enable us to measure
intermediate cardiovascular disease endpoints in
ﬁeld-based settings (e.g., blood pressure, arterial
function, heart rate variability); and new funding
mechanisms such as the Clean DevelopmentMechanism that facilitate large-scale intervention
implementation were not possible in the past. To
realize this potential, we will need to carefully
consider criteria for prioritization, identify which
circumstances and problems are best suited for
large diverse teams to address, and implement
rigorous ongoing self-evaluation based on the
concepts of results-based accountability. In the
case of advancing household air pollution research,
investigators will need to coordinate study of social
determinants and environment with classical
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